2026-01-02 - Analysis Report
Okay, here's a comprehensive analysis of Lam Research Corp (LRCX) based on the provided data.

**1. Return Rate Comparison (vs. S&P 500)**

*   **Company Overview:** Lam Research Corp designs, manufactures, markets, and services semiconductor processing equipment used in the fabrication of integrated circuits.
*   **LRCX Cumulative Return:** 220.55%
*   **VOO (S&P 500) Cumulative Return:** 91.40%
*   **Divergence:**
    *   **Current:** 115.5
    *   **Relative Divergence:** 93.0

**Analysis:** Lam Research has significantly outperformed the S&P 500, with a cumulative return far exceeding the index. The divergence between LRCX and VOO is considerable. The relative divergence of 93.0 suggests that the current outperformance is near the top end of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha  | Beta | Cap(B) |
|------------|---------|--------|--------|------|--------|
| 2016-2018  | 1.0%   | 99.4%  | -2.0%  | 1.6  | 17.2   |
| 2017-2019  | 38.0%  | 99.4%  | 21.0%  | 1.7  | 36.9   |
| 2018-2020  | 57.0%  | 99.3%  | 36.0%  | 1.5  | 59.5   |
| 2019-2021  | 105.0% | 63.8%  | 62.0%  | 1.6  | 90.7   |
| 2020-2022  | -11.0% | 94.1%  | -9.0%  | 1.6  | 53.0   |
| 2021-2023  | -14.0% | 94.1%  | -15.0% | 1.8  | 98.8   |
| 2022-2024  | -47.0% | 91.7%  | -66.0% | 1.9  | 91.1   |
| 2023-2025  | 150.0% | 73.6%  | 88.0% | 2.0  | 215.9  |

**Analysis:**

*   **Beta:** The beta consistently remains above 1, indicating that LRCX's price is more volatile than the market (S&P 500). It has been trending higher, reaching 2.0 in the 2023-2025 period, showing heightened sensitivity to market movements.
*   **Alpha:** Alpha fluctuates significantly. It was negative during 2016-2018, 2020-2022, 2021-2023, and 2022-2024, suggesting underperformance compared to what would be expected given its beta. However, it was strongly positive during the 2017-2019, 2018-2020, 2019-2021 and especially 2023-2025 periods, indicating significant outperformance.
*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows substantial growth potential but also periods of decline.
*   **MDD:** The Maximum Drawdown (MDD) has varied. It was extremely high between 2016 and 2024, indicating significant potential losses during those periods. However, it decreased to 73.6% between 2023 and 2025, indicating a lower risk of significant losses during that period.
*   **Cap(B):** Market capitalization has generally increased, especially with the recent rally in 2023-2025, but also experienced decline between 2020 and 2024, suggesting instability in market capitalization.

**2. Recent Stock Price Fluctuations**

*   **Current Price:** 171.18
*   **Previous Close:** 173.78
*   **Price Change:** -1.5
*   **5-day SMA:** 175.25
*   **20-day SMA:** 167.39
*   **60-day SMA:** 156.16

**Analysis:** The stock price is currently below its 5-day Simple Moving Average (SMA) but above its 20-day and 60-day SMAs. This suggests a short-term downward trend but a longer-term upward trend. The recent decline in price (-1.5) is a continuation of this short-term trend.

**3. RSI, PPO Index, and Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommended)
*   **RSI:** 52.81
*   **PPO:** 0.1076
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.80) Dividend_0.26
*   **Recent (20 days) relative divergence change:** -6.2 (short-term decline)
*   **Expected Return:** 44.19%

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a medium-risk investment environment.
*   **RSI:** An RSI of 52.81 indicates a neutral market sentiment, neither overbought nor oversold.
*   **PPO:** The positive PPO indicates that the shorter-term moving average is above the longer-term moving average, generally suggesting an upward trend.
*   **Hybrid Signal:** The hybrid signal suggests buying 90% of available cash, supporting the medium-risk investment sentiment.
*   **Divergence Change:** Recent divergence change shows a short-term decline.
*   **Expected Return:** The expected return of 44.19% is substantial, suggesting potential for significant gains if held long-term.

**4. Recent News & Significant Events**

*   **Positive Sentiment:** Several news articles express bullish sentiment on Lam Research, highlighting its potential for benefiting from cyclical demand.
*   **Stock Price Fluctuations:** News indicates slight pullbacks potentially due to year-end tech selloffs.
*   **Analyst Confidence:** Wall Street remains largely positive on LRCX.
*   **Options Activity:** Continued trading in LRCX options demonstrates ongoing investor interest.

**Concrete Headlines Analysis:**

*   **"Lam Research (LRCX) Stock Is Up, What You Need To Know":** Suggests generally positive performance.
*   **"Lam Research (NASDAQ:LRCX) Stock Price Down 1.5% - Here's What Happened":**  Confirms the recent price dip. It is critical to understand the reasons behind this decrease.
*   **"Wall Street bullish on Lam Research Corporation (LRCX), hereâ€™s what you need to know":** Reinforces positive analyst sentiment.
*   **"Lam Research (LRCX) stock slips after hours as year-end tech pullback hits chip tools":**  Links price decrease to broader market trends, not necessarily company-specific issues.
*   **"February 2026 Options Now Available For Lam Research (LRCX)":**  Indicates continued liquidity and trading interest in the stock.
*   **"Lam Research Corporation (LRCX) is Benefitting from Cyclical Demand":**  Highlights a key driver for LRCX's positive performance.

**4-2. Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 1.79 (Buy)
*   **Number of Opinions:** 29
*   **Target Price:**
    *   **Average:** 169.83
    *   **High:** 210.00
    *   **Low:** 115.00

**Analysis:** The analyst consensus is strongly positive, with a "Buy" rating and a high number of opinions. However, the average target price is lower than the current market price, so the stock might be overvalued at the moment. The high target price of $210.00 suggests some analysts believe there is still significant upside potential.

**5. Recent Earnings Analysis:**

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-10-24 | 1.24 | 5.32 B$   |
| 2025-04-25 | 1.04 | 4.72 B$   |
| 2025-01-31 | 0.93 | 4.38 B$   |
| 2024-10-28 | 0.86 | 4.17 B$   |
| 2025-10-24 | 0.86 | 4.17 B$   |

**Analysis:** Both EPS (Earnings Per Share) and Revenue have shown a general upward trend over the past year, indicating solid financial performance by the company. However, there is duplicate data entry of 2024-10-28.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $5.32B  | 50.43%        |
| 2025-06-30   | $5.17B  | 50.08%        |
| 2025-03-31   | $4.72B  | 49.02%        |
| 2024-12-31   | $4.38B  | 47.37%        |
| 2024-09-30   | $4.17B  | 48.05%        |

**Analysis:** Both Revenue and Profit Margin have generally increased over the past five quarters, demonstrating improved financial health and operational efficiency.

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
|--------------|----------|----------|
| 2025-09-30   | $10.19B  | 15.39%   |
| 2025-06-30   | $9.86B   | 17.44%   |
| 2025-03-31   | $9.51B   | 13.99%   |
| 2024-12-31   | $8.81B   | 13.52%   |
| 2024-09-30   | $8.47B   | 13.18%   |

**Analysis:** Equity has been steadily increasing, indicating growth in the company's net worth. Return on Equity (ROE) has fluctuated but has generally remained high, showing efficient use of shareholder equity to generate profits.

**7. Comprehensive Analysis (Summary)**

Lam Research (LRCX) has demonstrated significant outperformance compared to the S&P 500, driven by strong financial performance, positive analyst sentiment, and benefiting from cyclical demand in the semiconductor industry.

*   **Positives:**
    *   Substantial outperformance against the S&P 500.
    *   Strong revenue and earnings growth.
    *   Increasing equity and high ROE.
    *   Positive analyst consensus ("Buy").
    *   High expected return.
*   **Negatives/Concerns:**
    *   Recent short-term price decline.
    *   Average analyst target price lower than current price.
    *   High historical beta, indicating higher volatility.
*   **Overall:**

LRCX appears to be a fundamentally strong company with good growth prospects. The short-term price fluctuations and slightly negative analyst target price warrant monitoring. The high beta suggests a potentially volatile ride, but the high expected return could compensate for the risk.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.